OPKO Health Total Assets 2010-2024 | OPK

OPKO Health total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,256
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.078B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $205.491B 25.07
Intuitive Surgical (ISRG) United States $191.931B 100.35
Alcon (ALC) Switzerland $42.651B 28.54
Edwards Lifesciences (EW) United States $41.817B 26.55
IQVIA Holdings (IQV) United States $37.469B 20.64
IDEXX Laboratories (IDXX) United States $36.904B 43.46
DexCom (DXCM) United States $30.627B 46.12
Waters (WAT) United States $23.276B 34.42
STERIS (STE) Ireland $21.284B 24.50
SONOVA HOLDING (SONVY) Switzerland $20.097B 0.00
Hologic (HOLX) United States $17.200B 18.58
Fresenius Medical Care AG KGaA (FMS) Germany $14.078B 14.45
Sysmex ADR (SSMXY) Japan $13.104B 41.09
Globus Medical (GMED) United States $11.291B 28.59
Penumbra (PEN) United States $9.244B 90.55
Masimo (MASI) United States $9.076B 43.92
Teleflex (TFX) United States $8.687B 13.85
Glaukos (GKOS) United States $7.647B 0.00
PROCEPT BioRobotics (PRCT) United States $4.828B 0.00
Integer Holdings (ITGR) United States $4.639B 26.30
Veracyte (VCYT) United States $3.314B 99.44
Inari Medical (NARI) United States $3.126B 0.00
LivaNova (LIVN) United Kingdom $2.714B 15.67
Nihon Kohden (NHNKY) Japan $2.347B 17.83
TransMedics (TMDX) United States $2.344B 74.30
Elekta AB (EKTAY) Sweden $2.216B 19.92
Tandem Diabetes Care (TNDM) United States $2.108B 0.00
Integra LifeSciences Holdings (IART) United States $1.881B 9.83
RxSight (RXST) United States $1.599B 0.00
Alphatec Holdings (ATEC) United States $1.363B 0.00
Artivion (AORT) United States $1.216B 80.56
Pulse Biosciences (PLSE) United States $1.152B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.852B 14.48
Paragon 28 (FNA) United States $0.837B 0.00
Mesa Laboratories (MLAB) United States $0.712B 16.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.693B 37.47
AxoGen (AXGN) United States $0.646B 0.00
Pacific Biosciences Of California (PACB) United States $0.597B 0.00
SiBone (SIBN) United States $0.570B 0.00
OrthoPediatrics (KIDS) United States $0.544B 0.00
Semler Scientific (SMLR) United States $0.515B 30.30
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.441B 23.84
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.370B 0.00
AngioDynamics (ANGO) United States $0.351B 0.00
CVRx (CVRX) United States $0.331B 0.00
NeuroPace (NPCE) United States $0.327B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.210B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.157B 0.00
Sensus Healthcare (SRTS) United States $0.143B 15.26
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.094B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Vicarious Surgical (RBOT) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
908 Devices (MASS) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00